Found: 6
Select item for more details and to access through your institution.
Platelet-expressed immune checkpoint regulator GITRL in breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 9, p. 2483, doi. 10.1007/s00262-021-02866-y
- By:
- Publication type:
- Article
The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 6, p. 935, doi. 10.1007/s00262-018-2151-y
- By:
- Publication type:
- Article
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6122, doi. 10.3390/cancers13236122
- By:
- Publication type:
- Article
Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 277, doi. 10.3390/cancers11030277
- By:
- Publication type:
- Article
Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.653081
- By:
- Publication type:
- Article
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.917834
- By:
- Publication type:
- Article